325 related articles for article (PubMed ID: 15950543)
1. Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes.
Sellins K; Fradkin L; Liggitt D; Dow S
Mol Ther; 2005 Sep; 12(3):451-9. PubMed ID: 15950543
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice.
Nomura T; Yasuda K; Yamada T; Okamoto S; Mahato RI; Watanabe Y; Takakura Y; Hashida M
Gene Ther; 1999 Jan; 6(1):121-9. PubMed ID: 10341884
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the type of liposome involving cytokine production induced by non-CpG Lipoplex in macrophages.
Yasuda S; Yoshida H; Nishikawa M; Takakura Y
Mol Pharm; 2010 Apr; 7(2):533-42. PubMed ID: 20047296
[TBL] [Abstract][Full Text] [Related]
4. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.
Huarte E; Larrea E; Hernández-Alcoceba R; Alfaro C; Murillo O; Arina A; Tirapu I; Azpilicueta A; Hervás-Stubbs S; Bortolanza S; Pérez-Gracia JL; Civeira MP; Prieto J; Riezu-Boj JI; Melero I
Mol Ther; 2006 Jul; 14(1):129-38. PubMed ID: 16627004
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.
Sakurai F; Terada T; Maruyama M; Watanabe Y; Yamashita F; Takakura Y; Hashida M
Cancer Gene Ther; 2003 Sep; 10(9):661-8. PubMed ID: 12944985
[TBL] [Abstract][Full Text] [Related]
6. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.
Mitsui M; Nishikawa M; Zang L; Ando M; Hattori K; Takahashi Y; Watanabe Y; Takakura Y
J Gene Med; 2009 May; 11(5):435-43. PubMed ID: 19291673
[TBL] [Abstract][Full Text] [Related]
7. The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes.
Sakurai F; Terada T; Yasuda K; Yamashita F; Takakura Y; Hashida M
Gene Ther; 2002 Aug; 9(16):1120-6. PubMed ID: 12140741
[TBL] [Abstract][Full Text] [Related]
8. Type I interferon response against viral and non-viral gene transfer in human tumor and primary cell lines.
Rautsi O; Lehmusvaara S; Salonen T; Häkkinen K; Sillanpää M; Hakkarainen T; Heikkinen S; Vähäkangas E; Ylä-Herttuala S; Hinkkanen A; Julkunen I; Wahlfors J; Pellinen R
J Gene Med; 2007 Feb; 9(2):122-35. PubMed ID: 17191255
[TBL] [Abstract][Full Text] [Related]
9. Persistent interferon transgene expression by RNA interference-mediated silencing of interferon receptors.
Takahashi Y; Vikman E; Nishikawa M; Ando M; Watanabe Y; Takakura Y
J Gene Med; 2010 Sep; 12(9):739-46. PubMed ID: 20821744
[TBL] [Abstract][Full Text] [Related]
10. Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity.
Tan Y; Liu F; Li Z; Li S; Huang L
Mol Ther; 2001 May; 3(5 Pt 1):673-82. PubMed ID: 11356072
[TBL] [Abstract][Full Text] [Related]
11. Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA.
Thierry AR; Rabinovich P; Peng B; Mahan LC; Bryant JL; Gallo RC
Gene Ther; 1997 Mar; 4(3):226-37. PubMed ID: 9135736
[TBL] [Abstract][Full Text] [Related]
12. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration.
Liu F; Qi H; Huang L; Liu D
Gene Ther; 1997 Jun; 4(6):517-23. PubMed ID: 9231067
[TBL] [Abstract][Full Text] [Related]
13. Using disaccharides to enhance in vitro and in vivo transgene expression mediated by a lipid-based gene delivery system.
Tseng WC; Tang CH; Fang TY; Su LY
J Gene Med; 2007 Aug; 9(8):659-67. PubMed ID: 17611953
[TBL] [Abstract][Full Text] [Related]
14. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.
Cemazar M; Sersa G; Wilson J; Tozer GM; Hart SL; Grosel A; Dachs GU
Cancer Gene Ther; 2002 Apr; 9(4):399-406. PubMed ID: 11960291
[TBL] [Abstract][Full Text] [Related]
15. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma.
Wu A; Oh S; Ericson K; Demorest ZL; Vengco I; Gharagozlou S; Chen W; Low WC; Ohlfest JR
Cancer Gene Ther; 2007 Jun; 14(6):550-60. PubMed ID: 17415381
[TBL] [Abstract][Full Text] [Related]
16. Focal arterial transgene expression after local gene delivery.
Ma X; Glover C; Miller H; Goldstein J; O'Brien E
Can J Cardiol; 2001 Aug; 17(8):873-83. PubMed ID: 11521130
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models.
Tüting T; Gambotto A; Baar J; Davis ID; Storkus WJ; Zavodny PJ; Narula S; Tahara H; Robbins PD; Lotze MT
Gene Ther; 1997 Oct; 4(10):1053-60. PubMed ID: 9415311
[TBL] [Abstract][Full Text] [Related]
18. TLR9-dependent systemic interferon-beta production by intravenous injection of plasmid DNA/cationic liposome complex in mice.
Yoshida H; Nishikawa M; Yasuda S; Mizuno Y; Toyota H; Kiyota T; Takahashi R; Takakura Y
J Gene Med; 2009 Aug; 11(8):708-17. PubMed ID: 19462411
[TBL] [Abstract][Full Text] [Related]
19. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
[TBL] [Abstract][Full Text] [Related]
20. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
